American Pharmacy News
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • Home
  • »
  • Stories
  • »
  • American Pharmacy News Reports

PhRMA’s Molly Jenkins on 340B program: 'without any evidence that patients benefit'

E. A. Stiles | Feb 26, 2026
Molly Jenkins, Senior Director of Public Affairs at PhRMA

Molly Jenkins of PhRMA said increased scrutiny of the federal 340B drug pricing program highlights concerns about rising costs without clear patient benefits. Read More »

Georgia State Board of Pharmacy issues new guidelines for treatment provider approval

A. L. Lopez | Feb 26, 2026
Cecil H.  Cordle Georgia Board Of Pharmacy President

The Georgia State Board of Pharmacy has announced the adoption of Board Policy #9. Read More »

South Dakota launches first round of proposals under rural health transformation initiative

A. L. Lopez | Feb 25, 2026
Melissa Magstadt, Secretary of Health

The South Dakota Department of Health has announced the release of its first round of Requests for Proposals (RFPs) under the Rural Health Transformation initiative. Read More »

U.S. Representative Evans on PBMs: 'Pharmacy Benefit Managers — the middlemen between insurers and providers — have driven up drug costs for years'

J. A. Adkins | Feb 23, 2026
Gabe Evans, Representative for Colorado's 8th Congressional District

U.S. Representative Gabe Evans said pharmacy benefit managers have contributed to rising prescription drug costs and highlighted recent congressional action aimed at reforming their practices. Read More »

Building America’s Future announces claims of lobbying group blocking 340B reform for profit

E. A. Stiles | Feb 18, 2026
Chris Jankowski, President of Building America's Future

Building America’s Future claims a lobbying group is blocking reforms aimed at increasing transparency in the federal drug discount program known as 340B. Read More »

Mark Cuban on PBMs: 'PBMs got stronger because everyone thinks they can’t cheat any more'

W. K. Reid | Feb 16, 2026
Mark Cuban, Founder of Mark Cuban Cost Plus Drug Company

Mark Cuban says new rules targeting pharmacy benefit managers will not shift pricing power away from industry leaders controlling drug rebates. Recent reports highlight continued market dominance by three major PBMs despite regulatory efforts. Experts point to rebate structures as a key factor affecting patient costs. Read More »

Analysis examines flaws and potential reforms in the 340B drug discount program

L. T. Olson | Feb 16, 2026
Frederik Cyrus Roeder‏ - ‏Managing Director Consumer Choice Center

Fred Roeder from Consumer Choice Center analyzes challenges in the 340B Drug Discount Program. He highlights issues with post-dispensing eligibility checks and suggests a rebate model as a solution. Read More »

Pharmacist-attorney Lee: DOL proposal could 'force PBMs to disclose how they actually make money'

M. S. Trujillo | Feb 11, 2026
Dae Lee, Certified Pharmacy Benefits Specialist, Buchanan Ingersoll Rooney

Dae Y. Lee called attention to a proposed Department of Labor rule that would require pharmacy benefit managers to reveal details about their revenue practices. He encouraged stakeholders to submit public comments before the March 31 deadline. State audits and legal actions have highlighted ongoing concerns over spread pricing and retroactive fees. Read More »

NCPA CEO urges Congress to address impact of health care consolidation

Y. Y. Jacobsen | Feb 11, 2026
B. Douglas Hoey CEO

National Community Pharmacists Association CEO B. Douglas Hoey testified before the House Energy and Commerce Committee’s Subcommittee on Health, urging Congress to address what he described as harmful effects of consolidation among large pharmacy... Read More »

UCSF Professor on 340B: Research shows ‘340B program increases healthcare costs by over $1B'

M. S. Trujillo | Feb 9, 2026
Anthony DiGiorgio, Neurosurgeon, University of California

Anthony DiGiorgio from UCSF highlights concerns regarding the financial impact of the 340B drug discount program on taxpayers and employer plans. Read More »

White House signs H.R. 7148 into law, tightening rules on PBMs in effort to lower drug prices

E. A. Stiles | Feb 5, 2026
Donald Trump, United States President

Congressional bill H.R. 7148 has been signed into law by the White House, introducing reforms targeting pharmacy benefit manager practices in Medicare Part D. The legislation aims to shift compensation structures away from rebate-linked incentives... Read More »

FTC secures concessions from Cigna’s Express Scripts after probe into pharmacy practices

Y. Y. Jacobsen | Feb 4, 2026
B. Douglas Hoey CEO

The Federal Trade Commission (FTC) has announced that Cigna’s Express Scripts will make significant changes to its business practices following a settlement aimed at addressing concerns over drug pricing and competition in the pharmacy sector. Read More »

South Dakota reports possible measles exposures in Milbank and Brookings

J. S. Schmidt | Feb 4, 2026
Melissa Magstadt, Secretary of Health

Public health officials have announced that individuals may have been exposed to measles at several locations in Milbank and Brookings, South Dakota. Read More »

Rep. Krishnamoorthi: PBMs 'inflate prescription prices and squeeze local pharmacies to pad their profits'

W. K. Reid | Feb 3, 2026
Raja Krishnamoorthi, Representative for Illinois' 8th District

U.S. Representative Raja Krishnamoorthi advocates for a bipartisan bill aimed at reforming pharmacy benefit manager practices that allegedly inflate drug prices. Read More »

Trump signs first major PBM reform bill backed by NCPA

A. L. Lopez | Feb 3, 2026
B. Douglas Hoey CEO

The National Community Pharmacists Association (NCPA) has expressed support for new federal reforms targeting pharmacy benefit manager (PBM) practices, which were signed into law by President Donald Trump. Read More »

NCPA launches expert panel program for state pharmacy associations

J. S. Schmidt | Jan 29, 2026
B. Douglas Hoey CEO

The National Community Pharmacists Association (NCPA) has announced the launch of a new program designed to assist state pharmacy associations in advancing legislation that benefits both pharmacies and patients. Read More »

Drug Channels President Fein: 340B pharmacies 'don't increase patient access'

E. A. Stiles | Jan 29, 2026
Adam J. Fein, President of Drug Channels Institute

The article discusses concerns about the effectiveness of the expanding 340B drug discount program originally designed for low-income patient support but now criticized for benefiting providers more than patients directly due to spread pricing... Read More »

Concerns rise over pharmacy benefit managers' impact on rural access

S. D. Rosales | Jan 27, 2026
Matt Wallace, Political Commentator

Matt Wallace highlights concerns about pharmacy benefit managers' practices affecting rural areas. Read More »

Emma Rooth appointed CEO of PCCA UK by Precision Health Holdings

J. S. Schmidt | Jan 26, 2026
Jim Smith President

Emma Rooth has been named Chief Executive Officer of PCCA UK, according to an announcement from Precision Health Holdings, the parent company of PCCA UK. Read More »

PhRMA CEO Ubl: 340B is not 'improving patient access or lowering drug costs'

J. A. Adkins | Jan 26, 2026
Stephen J. Ubl, President & CEO of PhRMA

The rapid expansion of the 340B Drug Pricing Program has sparked concerns over its effectiveness in improving access or reducing costs. Read More »

  • «
  • 1
  • 2
  • 3
  • 4
  • 5 (current)
  • 6
  • 7
  • ...
  • 181
  • 182
  • »
Trending

Sally Pipes, President & CEO of Pacific Research Institute

Pacific Research Institute CEO on 340B Drug Pricing Program: 'Inject some badly needed transparency into 340B'

Jonathan Levitt, Founding Partner, Frier Levitt

Frier Levitt partner on CVS Health 340B lawsuits: CVS diverted funds ‘designated to help safety-net hospitals care for the most vulnerable’

West Cuthbert, Senior Fellow, American Resolve Action

American Resolve Action Senior Fellow on 340B reform: Oversight 'could prevent billions of dollars in annual waste, fraud, and abuse'

Brian Hanna, Executive Director of the Cannabis Regulatory Agency

Cannabis Regulatory Agency seeks new members for diversity, equity, and inclusion workgroup

B. Douglas Hoey CEO

Tennessee enacts law banning pharmacy benefit managers from owning pharmacies

Copyright © 2026 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up